NCT02922569

Brief Summary

This study is a parallel arm, double-blind, randomized, controlled clinical trial to assess the safety and efficacy of an experimental software program designed to improve cognitive functions versus a computer-based software control. Both the study and the software being investigated meet the criteria of Non-Significant Risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 4, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

March 31, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2020

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2020

Completed
Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

3.4 years

First QC Date

September 29, 2016

Last Update Submit

December 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in performance on global cognitive composite score

    Change in performance on global cognitive composite score based on the average of all normalized assessment measures.

    At 3 months and at 6 months

Secondary Outcomes (8)

  • Changes in performance on processing speed composite score

    At 3 months and at 6 months

  • Changes in performance on memory composite score

    At 3 months and at 6 months

  • Changes in performance on executive function composite score

    At 3 months and at 6 months

  • Change in functional performance

    At 3 months and at 6 months

  • Change in TBI functional status

    At 3 months and at 6 months

  • +3 more secondary outcomes

Other Outcomes (12)

  • Change in Neurobehavioral Symptoms

    At 3 months and at 6 months

  • Change in PTSD Symptoms

    At 3 months and at 6 months

  • Change in Depressive Symptoms

    At 3 months and at 6 months

  • +9 more other outcomes

Study Arms (2)

Experimental Treatment

EXPERIMENTAL

Computerized plasticity-based adaptive cognitive training and mindfulness training requiring a total maximum of 60 treatment sessions, up to 5 sessions per week, 40 minutes per session.

Other: Computerized Plasticity-Based Adaptive Cognitive TrainingOther: Mindfulness Training

Active Comparator

ACTIVE COMPARATOR

Commercially available computerized training and traumatic brain injury information session requiring a total maximum of 60 treatment sessions, up to 5 sessions per week, 40 minutes per session.

Other: Commercially available computerized trainingOther: Traumatic Brain Injury Information Session

Interventions

Thirty minutes of training on computerized exercises that targets processing speed, memory and attention.

Experimental Treatment

Thirty minutes of training on computerized, casual video games.

Active Comparator

Ten minutes of using an online training course that teaches skills to help overcome ongoing life stressors.

Experimental Treatment

Ten minutes of viewing traumatic brain injury related news, information, and programs.

Active Comparator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be 18 years of age or older
  • Participants must have diagnosis of mild traumatic brain injury (mTBI) confirmed by Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF)
  • Participants must have persistent cognitive dysfunction confirmed by an objective measure (Automated Neuropsychological Assessment Metrics (ANAM) TBI Battery with a score at least one standard deviation below the age-adjusted norm for a military sample) or a subjective measure (Ruff Neurobehavioral Inventory (RNBI) with a score of greater than 70 on any of the four cognitive scales (Attention, Memory, Language, Executive)
  • Participants must be at least six months out from their most recent traumatic brain injury (TBI), concussion, and/or blast exposure
  • Participant must be a fluent English speaker
  • Participants must score ≥ 70 on the Wechsler Test of Adult Reading (WTAR)
  • Participants must have adequate sensorimotor capacity to perform the program, including visual capacity adequate to read from a computer screen at a normal viewing distance, auditory capacity adequate to understand normal speech, and motor capacity adequate to control a computer mouse

You may not qualify if:

  • Participants with history of TBI with loss of consciousness for more than 24 hours or post-traumatic amnesia for more than 7 days
  • Participants with a history of penetrating head wounds
  • Participants who are in-patients
  • Participants with a diagnosis of an illness or condition with known cognitive consequences (e.g., schizophrenia, bipolar disorder, cancer, multiple sclerosis)
  • Participants with active suicidal ideation with specific plan and intent or suicide-related behaviors within 2 months of consent as measured by the Columbia-Suicide Severity Rating Scale (C-SSRS)
  • Participants showing signs of intoxication due to current substance abuse (including alcohol and/or illegal drugs) during any in person visit
  • Participants with clinically significant visual field deficits
  • Participants judged to be lacking effort
  • Participants with problems performing assessments or comprehending or following spoken instructions
  • Participants enrolled in a concurrent clinical trial involving an investigational pharmaceutical, nutraceutical, medical device, or behavioral treatment for TBI that could affect the outcome of this study
  • Participant with self-reported claustrophobia or physician-reported implanted devices (e.g. pacemakers, cochlear implants, aneurysm clips, etc.) and pregnant women will not be able to participate in MRI portion of study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Veterans Affairs Connecticut Health Care System

West Haven, Connecticut, 06516, United States

Location

MeSH Terms

Conditions

Brain Concussion

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, Nonpenetrating

Study Officials

  • Kyu Lee, PhD

    Posit Science Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2016

First Posted

October 4, 2016

Study Start

March 31, 2017

Primary Completion

August 30, 2020

Study Completion

September 14, 2020

Last Updated

December 23, 2025

Record last verified: 2025-12

Locations